Clinical Trial Update: "A Prospective Study of the Efficacy of Intracameral Dexamethasone (Dexycu™) Compared to Standard of Care Treatment for Post-Cataract Surgical Pain and Anterior Chamber Inflammation" [Phase 4]

View source ↗

Summary

Completed Phase 4 trial evaluating intracameral dexamethasone (Dexycu) versus standard care for post-cataract surgery pain and anterior chamber inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Dexycu (dexamethasone intraocular suspension)

Snippet

Sponsor: The Eye Institute of West Florida | Conditions: Cataract | Phase 4 | Status: COMPLETED